A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease

Summary

The goal of this clinical trial is to assess the safety and tolerability profile of belantamab. The study will also assess how the levels of belantamab change over time and body's reaction to it in participants with stable but active autoimmune disease.

Timeline

Start

2024-06-03

Primary completion

2025-07-08

Completion

2025-07-08

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications